NLRP3 and obesity due to melanocortin 4 receptor deficiency: Of note, tranilast induced weight loss [154] and exhibited antidiabetic properties in mice via NLRP3 inhibition [155], suggesting that this drug might reduce obesity-associated comorbidities.